adenovirus gene therapy (Fondazione Telethon)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameadenovirus gene therapy (Fondazione Telethon)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionArylsulfatase B gene transference
TargetsArylsulfatase B
Therapy Area/IndicationsMucopolysaccharidosis VI
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFondazione Telethon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFondazione Telethon
Active IndicationsN/A
Inactive IndicationsMucopolysaccharidosis VI

Other Information

ATC CodeN/A
Related LinksN/A